康宁杰瑞制药-B(09966.HK) 发盈喜,与上年度亏损2.11亿人民币相比,预计2024年度利润不少于1.5亿人民币,首次实现年度盈利。主要基于三项授权合作和销售收入。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-04 16:25。)过往派息公布日期派息事项派息内容2024/08/15中期业绩无派息2024/03/28末期业绩无派息2023/08/23中期业绩无派息...
Source Link康宁杰瑞制药-B(09966.HK) 发盈喜,与上年度亏损2.11亿人民币相比,预计2024年度利润不少于1.5亿人民币,首次实现年度盈利。主要基于三项授权合作和销售收入。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-04 16:25。)过往派息公布日期派息事项派息内容2024/08/15中期业绩无派息2024/03/28末期业绩无派息2023/08/23中期业绩无派息...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.